PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for May 14, 2009 Subscribe to this News Feed    
 

The Mulligan Law Firm is Investigating Potential Calaxo® Screw Injury Cases

The Mulligan Law Firm is pleased to announce the addition of Smith & Nephew's Calaxo® Screw to its medical-device litigation service.

Dallas, TX (PRWEB) May 14, 2009 -- The Mulligan Law Firm (http://www.mulliganlaw.com) has begun to evaluate and investigate potential injuries caused by the Calaxo® Screw medical-device.

Smith & Nephew's Calaxo® Screw received approval for use in March 2006, and was used until August 2007. At that point in time, Smith & Nephew recalled the device after a number of patients experienced swelling, pain, fluid build-up, and screw fragmentation.

Specific details can be found at the official website of the U.S. Food & Drug Administration at the following FDA link: http://www.fda.gov/bbs/topics/ENFORCE/2008/ENF01049.html

Those who have been fitted with Smith & Nephew's Calaxo® Screw medical-device and who have suffered from joint-swelling, fever, excessive and/or constant pain, should contact The Mulligan Law Firm immediately.

As a part of its medical-device litigation service, The Mulligan Law Firm is now offering free evaluation of possible claims connected to health issues that may have resulted from the Calaxo® Screw.

Those who may have been injured are invited to contact The Mulligan Law Firm as soon as possible to discuss potential claims and litigation issues. The Mulligan Law Firm has medical-device litigation attorneys on stand-by right now to answer questions and offer advice.

The attorneys of The Mulligan Law Firm stress that in each and every personal injury case and lawsuit it is vital that measures are taken to preserve all available evidence, and to enable physicians and additional expert witnesses to evaluate any injuries at an in-depth level.

In addition, statutes of limitations require potential plaintiffs to act within statutory time-frames. Therefore, any failure or delay in contacting an attorney may cause a potential claimant to lose rights.

About The Mulligan Law Firm:

The Mulligan Law Firm was formed in 1995. The firm has successfully represented thousands of individuals in a wide variety of practice areas in federal and state courts throughout the United States, and has achieved recoveries for its clients exceeding well over $600 million U.S. dollars. The firm obtained an AV rating with Martindale-Hubbell which indicates very high to preeminent legal ability and very high ethical standards as established by confidential opinions from members of the Bar.

The Mulligan Law Firm would like to hear from people that have been injured by the Calaxo® Screw to discuss potential claims.

For more information on Smith & Nephew's Calaxo® Screw and The Mulligan Law Firm, see the web site: http://www.mulliganlaw.com

Calaxo® is a registered trademark of Smith & Nephew.

The Mulligan Law Firm's Texas, California, and Florida Lawyers / Attorneys are evaluating nationwide claims.

The Mulligan Law Firm represents clients throughout the United States in conjunction with local counsel licensed in other jurisdictions.

Contact:

Patrick J. Mulligan, Attorney / Lawyer*
Eric W. Gruenwald, Attorney / Lawyer+
The Mulligan Law Firm
214-219-9779, EXT. 245

*Licensed in Texas & Georgia
+ Licensed in California only

###

OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
Email this story to a colleague
CONTACT INFORMATION
Eric Gruenwald
The Mulligan Law Firm
214 219 9779 x245
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.